Related Experiment Video
Updated: May 27, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Inter-ethnic differences--how important is it in cancer treatment?
Winnie H Y Ling1, Soo Chin Lee
1Department of Hematology-Oncology, National University Cancer Institute, National University Health System, Singapore.
Annals of the Academy of Medicine, Singapore
|November 9, 2011
Summary
Inter-ethnic differences in drug pharmacokinetics and pharmacodynamics affect treatment responses. Physicians must consider these pharmacogenetic variations for safe and effective cancer therapy, especially with narrow therapeutic index drugs.
Area of Science:
- Pharmacogenomics
- Oncology
- Drug Metabolism
Background:
- Inter-ethnic variations in drug pharmacokinetics (PK) and pharmacodynamics (PD) influence treatment outcomes.
- Physicians must recognize these differences when applying data from diverse populations.
- Oncology treatments often involve drugs with narrow therapeutic indices, heightening the need for personalized approaches.
Purpose of the Study:
- To highlight the significance of inter-ethnic pharmacogenetic differences in cancer drug efficacy and safety.
- To inform Asian physicians about known variations relevant to commonly used anti-cancer agents.
Main Methods:
- Review of existing literature on inter-ethnic variations in drug response.
- Focus on commonly prescribed anti-cancer drugs with documented PK/PD differences across ethnic groups.
Main Results:
- Significant inter-ethnic variations exist in the metabolism and response to several key anti-cancer drugs.
- These differences can lead to altered efficacy and increased toxicity in specific patient populations.
Conclusions:
- Awareness of pharmacogenetic disparities is crucial for optimizing cancer treatment in diverse populations.
- Tailoring anti-cancer drug selection and dosing based on ethnic considerations can improve patient outcomes and minimize adverse events.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.